Somatic genetic alterations in BRCA2‐associated and sporadic male breast cancer

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Genes, Chromosomes and Cancer

• Publication date

  1999-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1098-2264(199901)24:1<56::AID-GCC8>3.0.CO;2-XPMID 9892109
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Involvement of Brca2 in DNA repair.

  1998cited by this paper
• Molecular cytogenetics of primary breast cancer by CGH

  1998cited by this paper
• BRCA1, BRCA2, and DNA damage response: collision or collusion?

  1998cited by this paper
• BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease.

  1998cited by this paper
• Vegetation-induced warming of high-latitude regions during the Late Cretaceous period

  1997cited by this paper
• Genome screening by comparative genomic hybridization.

  1997cited by this paper
• Male breast cancer: pathological and immunohistochemical features.

  1997influential reference
• Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations.

  1997cited by this paper
• MCF-7: the first hormone-responsive breast cancer cell line.

  1997cited by this paper
• A comparison outcome of male breast cancer with female breast cancer.

  1997cited by this paper
• Association of BRCA1 with Rad51 in mitotic and meiotic cells.

  1997cited by this paper
• Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population.

  1997cited by this paper
• AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.

  1997cited by this paper
• Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2

  1997cited by this paper
• The role of androgen receptor gene mutations in male breast carcinoma.

  1996cited by this paper
• A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes

  1996cited by this paper
• The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds

  1996cited by this paper
• BRCA2 germline mutations in male breast cancer cases and breast cancer families

  1996cited by this paper
• Identification of the breast cancer susceptibility gene BRCA2

  1995cited by this paper
• Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer.

  1995cited by this paper
• Loss of heterozygosity on the short arm of chromosome 8 in male breast carcinomas.

  1995cited by this paper
• Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors

  1994cited by this paper
• Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization.

  1994cited by this paper
• Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.

  1992cited by this paper
• Interphase cytogenetics of a male breast cancer.

  1991cited by this paper
• Head trauma and exposure to prolactin-elevating drugs as risk factors for male breast cancer.

  1988cited by this paper
• Risk factors for male breast cancer.

  1985cited by this paper

• Understanding, diagnosing, and treating pancreatic cancer from the perspective of telomeres and telomerase

  2024cites this paper
• Analysis of the Clinical Advancements for BRCA-Related Malignancies Highlights the Lack of Treatment Evidence for BRCA-Positive Male Breast Cancer

  2022cites this paper
• Genetic Landscape of Male Breast Cancer

  2021cites this paper
• Interplay between BRCA1 and GADD45A and Its Potential for Nucleotide Excision Repair in Breast Cancer Pathogenesis

  2020cites this paper
• Genotypic phenotypic correlation in male breast cancer

  2018cites this paper
• The cancer genetics and pathology of male breast cancer

  2016cites this paper
• EMSY copy number variation in male breast cancers characterized for BRCA1 and BRCA2 mutations

  2016cites this paper
• Methylation of RASSF10 promotes cell proliferation and serves as a docetaxel resistant marker in human breast cancer.

  2015cites this paper
• Copy number profiling by array comparative genomic hybridization identifies frequently occurring BRCA2‐like male breast cancer

  2015influential citation
• Male versus Female Breast Cancer : differences hidden behind similarities

  2014cites this paper
• Molecular profiling of male breast cancer - lost in translation?

  2014cites this paper
• Mutational profiling of familial male breast cancers reveals similarities with luminal A female breast cancer with rare TP53 mutations

  2014cites this paper
• Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship.

  2013cites this paper
• Male breast cancer: genetics, epigenetics, and ethical aspects.

  2013cites this paper
• Molecular Characterization of Male Breast Cancer

  2013cites this paper
• Prediction of "BRCAness" in breast cancer by array comparative genomic hybridization

  2012cites this paper
• Enhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancers

  2012cites this paper
• Genotyping and Phenotyping of Male Breast Cancer

  2012cites this paper
• Gene copy number variation in male breast cancer by aCGH

  2011cites this paper
• A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients

  2011cites this paper
• The Changing Role of Pathology in Breast Cancer Diagnosis and Treatment

  2011cites this paper
• High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer

  2011influential citation
• Therapeutic potential of PARP inhibitors for metastatic breast cancer

  2011cites this paper
• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.

  2010cites this paper
• Tumors of the Breast

  2010cites this paper
• Gene Copy Number Variation in Male Breast Cancer by aCGH

  2010cites this paper
• Characterization of the mouse and human breast cancer genome

  2010cites this paper
• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial.

  2010cites this paper
• Breast Diseases in Males

  2010cites this paper
• Male breast cancer.

  2010cites this paper
• Genetic heterogeneity by comparative genomic hybridization in BRCAx breast cancers.

  2008cites this paper
• 4.1. CHARACTERIZATION OF FAMILIAL NON-BRCA1/2 BREAST TUMORS BY LOSS OF HETEROZYGOSIT Y AND IMMUNOPHENOT YPING

  2008cites this paper
• Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976-1999.

  2008cites this paper
• Genetic Markers in Breast Tumors with Hereditary Predisposition

  2008cites this paper
• Genome‐wide analysis identifies 16q deletion associated with survival, molecular subtypes, mRNA expression, and germline haplotypes in breast cancer patients

  2008cites this paper
• Genetic susceptibility for breast cancer: how many more genes to be found?

  2007cites this paper
• Analysis of PALB2/FANCN-associated breast cancer families

  2007cites this paper
• Chromosomal aberrations detected by comparative genomic hybridization technique (CGH) in invasive ductal carcinoma of breast

  2007cites this paper
• Array-CGH and breast cancer

  2006cites this paper
• Characterization of Familial Non-BRCA1/2 Breast Tumors by Loss of Heterozygosity and Immunophenotyping

  2006cites this paper
• Basal-like breast cancer and the BRCA1 phenotype

  2006cites this paper
• Review Array-CGH and breast cancer

  2006cites this paper
• Comparative genomic hybridization analysis on male breast cancer

  2006influential citation
• Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization.

  2005cites this paper
• Epidemiology of male breast cancer.

  2005cites this paper
• Chapter 36 – Treatment of Male Breast Cancer

  2005cites this paper
• Frequent amplification and overexpression of CCND1 in male breast cancer

  2004cites this paper
• ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers

  2004cites this paper
• Genetic Predisposition to Male and Female Breast Cancer

  2004cites this paper
• BRCA 2 Mutations and Androgen Receptor Expression as Independent Predictors of Outcome of Male Breast Cancer Patients

  2003cites this paper
• Study in Italy Characteristics in Male Breast Cancer : A Population-based Mutation Status and Tumor BRCA 2 and BRCA 1 Updated Version

  2003cites this paper
• BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients.

  2003cites this paper
• BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.

  2003cites this paper
• BRCA 1 and BRCA 2 Mutation Status and Tumor Characteristics in Male Breast Cancer : A Population-based Study in Italy 1

  2003cites this paper
• Cytogenetic Alterations and Cytokeratin Expression Patterns in Breast Cancer: Integrating a New Model of Breast Differentiation into Cytogenetic Pathways of Breast Carcinogenesis

  2002cites this paper
• BRCA-1, BRCA-2 and Hereditary Breast Cancer

  2002cites this paper
• Comparative genomic hybridization analysis of benign and invasive male breast neoplasms.

  2002cites this paper
• Compilation of published comparative genomic hybridization studies.

  2002cites this paper
• BRCA1 and BRCA2 in DNA Repair and Genome Stability

  2001cites this paper
• Breast cancer-predisposing genes in Finnish breast and ovarian cancer families

  2001cites this paper
• [Genomic profiling: from molecular cytogenetics to DNA arrays].

  2001cites this paper
• Comparative Genomic Hybridization of Microdissected Familial Ovarian Carcinoma: Two Deleted Regions on Chromosome 15q Not Previously Identified in Sporadic Ovarian Carcinoma

  2001cites this paper
• Comparative genomic hybridization in inherited and sporadic ovarian tumors in Israel.

  2000cites this paper
• Tumour biology of a breast cancer at least partly reflects the biology of the tissue/epithelial cell of origin at the time of initiation - a hypothesis.

  2000cites this paper
• Commentary on “Prevalence of BRCA1 and BRCA2 Mutations in Male Breast Cancer Patients in Canada”

  2000cites this paper
• Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data.

  2000cites this paper
• Chromosome 8p alterations in sporadic andBRCA2 999del5 linked breast cancer

  2000cites this paper
• Cytogenetic heterogeneity and clonal evolution in synchronous bilateral breast carcinomas and their lymph node metastases from a male patient without any detectable BRCA2 germline mutation.

  2000cites this paper
• Predisposing genes in hereditary breast and ovarian cancer

  1999cites this paper
• The Brca1 and Brca2 proteins and tumor pathogenesis.

  1999cites this paper
• Androgen receptor gene alterations and chromosomal gains and losses in prostate carcinomas appearing during finasteride treatment for benign prostatic hyperplasia.

  1999cites this paper
• Androgen Receptor Gene Alterations and Chromosomal Gains and Losses in Prostate Carcinomas Appearing During Finasteride Treatment for Benign Prostatic Hyperplasia 1

  1999cites this paper